These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 138478)

  • 41. Pharmacologic disposition of chlorozotocin in mice.
    Mhatre RM; Green D; Panasci LC; Woolley PV; Schein PS
    Cancer Treat Rep; 1978 Aug; 62(8):1145-51. PubMed ID: 150943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of tetraacetylglucosamine mustard.
    Wampler GL; Nassiri SK; Hsiao YY; Bardos TJ; Regelson W
    Cancer Res; 1975 Aug; 35(8):1903-6. PubMed ID: 1149014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea].
    Durdyeva ED; Kukushkina GV; Gorbacheva KB
    Biull Eksp Biol Med; 1986 Feb; 101(2):192-5. PubMed ID: 3947737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
    Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
    Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
    Andrade Mena CE; Orbach-Arbouys S; Cosmatopoulos K; Mathé G
    Chemotherapy; 1986; 32(2):131-7. PubMed ID: 2938892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inhibition of DNA synthesis by cannabinoids.
    Carchman RA; Harris LS; Munson AE
    Cancer Res; 1976 Jan; 36(1):95-100. PubMed ID: 1248011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
    Ewig RA; Kohn KW
    Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823
    [No Abstract]   [Full Text] [Related]  

  • 55. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
    Rosenoff SH; Bostick F; Young RC
    Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
    [No Abstract]   [Full Text] [Related]  

  • 56. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
    Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
    Ostrovskaia LA; Sokolova IS; Gorbacheva LB
    Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.
    Lazarus P; Germina JS; Dufour M; Palmer G; Wallace D; Panasci LC
    Cancer Chemother Pharmacol; 1983; 11(3):159-61. PubMed ID: 6227421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.